Status:
WITHDRAWN
Noninvasive Spinal Cord Stimulation for Neurogenic and Idiopathic Overactive Bladder
Lead Sponsor:
University of Southern California
Collaborating Sponsors:
University of California, Los Angeles
Conditions:
Overactive Bladder
Incontinence, Urge
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Overactive bladder (OAB) affects 12-30% of the world's population. The accompanying urinary urgency, urinary frequency and incontinence can impair the ability to work, interact in social activities an...
Eligibility Criteria
Inclusion
- Age between 18 and 80 years
- Known diagnosis of overactive bladder, confirmed by:
- presence of urinary frequency, urgency
- frequent small-volume voids on frequency-volume chart
- high score on ICIQ-OAB, ICIQ-OABQOL, and OAB-q questionnaires
Exclusion
- Younger than 18 years of age
- Older than 80 years of age
- Presence of lower urinary tract symptoms suggestive of urinary retention or obstruction
- Finding of an elevated post-void residual (\>100 ml) on an ultrasonographic bladder scan
- History of spinal cord injury, spina bifida or other neurological disease affecting the spinal cord
- Acute or current urinary tract infection
- History of neuromodulation for overactive bladder (sacral nerve stimulation or peripheral tibial nerve stimulation)
- Current or planned pregnancy
Key Trial Info
Start Date :
March 24 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03753750
Start Date
March 24 2020
End Date
January 1 2022
Last Update
May 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Southern California
Los Angeles, California, United States, 90033